PhRMA calls for more di­verse in­fra­struc­ture up­grades to US emer­gency tri­als frame­work

The White House’s Of­fice of Sci­ence and Tech­nol­o­gy Pol­i­cy (OSTP) last year sought to find ways to bet­ter co­or­di­nate large-scale clin­i­cal tri­als in the US — as the UK lead by ex­am­ple dur­ing the pan­dem­ic — es­pe­cial­ly for these emer­gency clin­i­cal tri­als.

The lob­by­ing group PhRMA Tues­day called for more clin­i­cal tri­al di­ver­si­ty in un­der­served ar­eas, in­clud­ing by mak­ing par­tic­i­pa­tion less of a bur­den, and ex­pand­ing el­i­gi­bil­i­ty cri­te­ria when ap­pro­pri­ate.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER